Diagnosis: Drug-induced erythroderma
A 45-year-old male presented with generalized erythema and scaling two weeks after starting a new antihypertensive medication. The patient reported significant pruritus and discomfort, prompting an evaluation. Examination revealed widespread erythematous plaques with fine scaling, suggesting a drug-induced reaction.
A 45-year-old male presented with generalized erythema and scaling that began two weeks after the initiation of a new antihypertensive medication. He reported significant pruritus and discomfort, which prompted him to seek medical attention. On examination, the patient exhibited widespread erythematous plaques with fine scaling covering more than 90% of his body surface area.Generalized erythroderma affecting >90% of body surface area.Fine scaling noted on the plaques, particularly in flexural areas.Pruritus rated 8/10 on the visual analog scale.No mucosal involvement or systemic symptoms such as fever or lymphadenopathy.Previous stable skin condition without recent changes prior to medication initiation.
The patient reported the onset of symptoms two weeks after starting a new antihypertensive medication. He had no prior history of skin conditions and was previously stable on his medication regimen. There were no known drug allergies, and his family history was non-contributory. Socially, he denied recent travel or exposure to new products.Medication initiation: New antihypertensive medication started two weeks prior to presentation.No prior dermatologic issues: Patient had no history of skin diseases.Family history: Non-contributory; no history of similar reactions.Social history: No recent travel, new products, or dietary changes.Allergies: Denies any known drug allergies.
Acute / First-Line ManagementDiscontinue the offending medication immediately.Start systemic corticosteroids, such as prednisone 1 mg/kg/day for 1-2 weeks, tapering thereafter based on clinical improvement.Symptomatic relief with antihistamines for pruritus, e.g., cetirizine 10 mg daily.Moisturizers and emollients to maintain skin hydration.Workup and Diagnostic ConfirmationClinical diagnosis based on history and examination findings.Consider skin biopsy if diagnosis is uncertain or if there is lack of response to treatment.Laboratory tests may include complete blood count and liver function tests to assess for systemic involvement.Long-Term ManagementRegular follow-up to monitor for recurrence and manage any long-term sequelae.Education on avoiding the offending medication and alternatives for hypertension management.Consider referral to a dermatologist for persistent or complicated cases.
Psoriasis: Characterized by well-defined erythematous plaques covered with silvery scales, often with involvement of the scalp and nails.Atopic dermatitis: Typically presents with pruritic, erythematous papules or plaques, often with a history of atopy.Contact dermatitis: Erythematous, itchy rash localized to areas of contact with an irritant or allergen; often with vesicles or weeping.Exfoliative dermatitis: Severe scaling and erythema, often with systemic involvement; may be drug-induced or due to underlying skin disease.Cutaneous T-cell lymphoma: Presents with erythroderma and scaling, often with associated lymphadenopathy and pruritus.Viral exanthems: Often associated with fever and systemic symptoms; usually resolves spontaneously.Drug-induced hypersensitivity syndrome (DIHS): Associated with systemic symptoms and internal organ involvement; typically occurs 2-8 weeks after exposure to medications.Seborrheic dermatitis: Commonly affects the scalp and face, characterized by greasy, yellowish scales.
High-Yield PearlsMedication history: Always obtain a thorough medication history in patients with new-onset erythroderma.Discontinuation: Immediate discontinuation of the suspected offending drug is crucial in management.Systemic therapy: Systemic corticosteroids are often effective for severe drug-induced erythroderma.Skin biopsy: Consider biopsy for atypical presentations to rule out other conditions.Education: Educate patients about their condition and the importance of avoiding the triggering medication.Drug-induced erythroderma is a serious, potentially life-threatening condition that requires prompt recognition and management.
Tags: erythroderma, drug eruption